These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 32525724

  • 1. Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis.
    Zhao J, Wu J, He M, Cao M, Lei J, Luo H, Yi F, Ding J, Wei Y, Zhang W.
    Int J Hyperthermia; 2020; 37(1):624-633. PubMed ID: 32525724
    [Abstract] [Full Text] [Related]

  • 2. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y, Yu H, Qi L, Liu C, Feng Y, Qi J, Li J, Zhu Q.
    Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786
    [Abstract] [Full Text] [Related]

  • 3. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
    Jiang C, Cheng G, Liao M, Huang J.
    World J Surg Oncol; 2021 Mar 19; 19(1):81. PubMed ID: 33741001
    [Abstract] [Full Text] [Related]

  • 4. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T, Qi H, Shen L, Wu Y, Song Z, Cao F, Liu Y, Xie L, Chen S, Tang T, Li H, Zhang Y, Feng L, Zhang H, Chen J, Fan W.
    Int J Hyperthermia; 2022 Mar 19; 39(1):935-945. PubMed ID: 35853727
    [Abstract] [Full Text] [Related]

  • 5. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M, Zivin SP, Wroblewski K, Doshi T, Vasnani RJ, Van Ha TG.
    J Vasc Interv Radiol; 2015 Mar 19; 26(3):330-41. PubMed ID: 25534635
    [Abstract] [Full Text] [Related]

  • 6. Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Keshavarz P, Raman SS.
    Abdom Radiol (NY); 2022 Mar 19; 47(3):1009-1023. PubMed ID: 34982183
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD, Zhang LH, Ni JY, Jiang XY, Chen D, Chen YT, Sun HL, Luo JH, Xu LF.
    Korean J Radiol; 2018 Mar 19; 19(4):613-622. PubMed ID: 29962868
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY, Liu SS, Xu LF, Sun HL, Chen YT.
    World J Gastroenterol; 2013 Jun 28; 19(24):3872-82. PubMed ID: 23840128
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value.
    Liu J, Zhang W, Lu H, Li H, Zhou X, Li J, Han X.
    J Cancer Res Clin Oncol; 2022 Jul 28; 148(7):1781-1788. PubMed ID: 34405295
    [Abstract] [Full Text] [Related]

  • 13. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y, Cao Y, Ma H, Kan X, Zhou C, Liu J, Shi Q, Feng G, Xiong B, Zheng C.
    BMC Cancer; 2019 Oct 22; 19(1):983. PubMed ID: 31640620
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer - a systematic review and network meta-analysis of survival data.
    Chow R, Simone CB, Jairam MP, Swaminath A, Boldt G, Lock M.
    Acta Oncol; 2022 Apr 22; 61(4):484-494. PubMed ID: 34846988
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L, Ke Q, Lin N, Huang Q, Zeng Y, Liu J.
    Int J Hyperthermia; 2019 Apr 22; 36(1):1288-1296. PubMed ID: 31852267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S, Shi M, Shen L, Qi H, Wan W, Cao F, Xie L, Wu Y, Chen G, Mo J, Zhu G, Ye D, Zhang Y, Feng Z, Xu L, Fan W.
    Int J Hyperthermia; 2020 Apr 22; 37(1):384-391. PubMed ID: 32323585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.